Status:
UNKNOWN
Il-17 Levels in Intrahepatic Cholestasis of Pregnancy
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Conditions:
Intrahepatic Cholestasis of Pregnancy
Eligibility:
FEMALE
18-39 years
Brief Summary
The aim of this study is to investigate maternal and fetal serum IL-17 levels in pregnant women with intrahepatic cholestasis of pregnancy and to find out if Th-17 cells have a role in progress of int...
Detailed Description
Intrahepatic cholestasis of pregnancy (ICP) is the most prevalent pregnancy-specific liver disease. It occurs mainly in the second or third trimester of pregnancy. It typically resolves after delivery...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ICP
- \-
Exclusion
- multiple pregnancies known chronic illness
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01898832
Start Date
July 1 2013
End Date
July 1 2014
Last Update
March 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak
Ankara, Ankara, Turkey (Türkiye), 06080